Three years ago, Veritas Capital purchased Truven Health Analytics for $1.2 billion. Fast forward to Thursday, February 18, when IBM Corp. announced that it plans to pay $2.6 billion for Truven.

That aggressive purchase gives an idea of how serious IBM is about succeeding in the healthcare arena with its Watson Health technology, says John Moore, managing partner at Chilmark Research.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access